BofA Securities Downgrades Oscar Health Inc (OSCR) to Neutral

Go back to BofA Securities Downgrades Oscar Health Inc (OSCR) to Neutral

Baird Starts Oscar Health Inc (OSCR) at Outperform

May 29, 2024 4:26 PM EDT

Baird analyst Michael Ha initiates coverage on Oscar Health Inc (NYSE: OSCR) with a Outperform rating and a price target of $28.00.


For an analyst ratings summary and ratings history on Oscar Health Inc... More